Bright lights, big milestone. ✨ CTx001 is officially headed into the clinic! @ComplementTx celebrates FDA IND clearance in the heart of Times Square — lighting up the @Nasdaq tower for the second time. 🧬🚀 📰 Media coverage roundup ⬇️ #INDClearance #GeneTherapy #BiotechNews

🚀 Big milestone for @ComplementTx: We’ve received FDA IND clearance for CTx001, our lead gene therapy for Geographic Atrophy (GA). We’re now entering the clinic with Opti-GAIN, a first-in-human Phase I/II trial. A huge step for the team, and for patients. #INDClearance #CTx001

We welcome Kate to the team as our Vice President, Regulatory Affairs. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs

We welcome Jen to the team as our Vice President, Clinical Operations. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs

Please join us in extending a warm welcome to our Chief Technology Officer, Dr. Matthias Hebben! 🎉 Read more about Matthias and our continued growth in the full release here: bit.ly/3TbgxDr #biotech #ophthalmology #genetherapy #complement #chieftechnologyofficer #CTO

📢The first patient enrolled in our i-GAIN Natural History Study! We will be recruiting 250 patients with geographic atrophy (#GA) secondary to age-related macular degeneration (#AMD) across the UK and US over the next 12 months. Find out more here: bit.ly/465S2KW

We welcome Sofiya to the team as our Scientist, Pharmacology. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs

We welcome Thanos to the team as our Director, Pharmacology. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs

We welcome Rachel to the team as our Director, Biomarker/Bioanalytical. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs

We welcome Rachel to the team as our Senior Vice President, Development Operations. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs